Alan B. Bergman's most recent trade in 20/20 Biolabs Inc was a trade of 100,000 Stock Option done . Disclosure was reported to the exchange on April 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020 Biolabs Inc | Alan B. Bergman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2026 | 100,000 | 100,000 | - | - | Stock Option | |
| Smart for Life Inc | Alan B. Bergman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Smart for Life Inc | Alan B. Bergman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 35,000 | 50,000 | - | 0 | Common Stock |